GlassScriptPhysician profile
Fredric M Pieracci
NPI 1669652335
$18,246.88
in general payments reported to CMS, 2019-2025
7 companies · $8,114 in 2025
The $8,114 reported for 2025 was more than what 80% of Obesity Medicine (Internal Medicine) providers received nationally (typical 2025 total: $202).
See the full distribution for Obesity Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,867 · 2020: $77.94 · 2022: $23.54 · 2024: $164 · 2025: $8,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,718 · Travel and Lodging: $2,056 · Food and Beverage: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,717.88 |
| Travel and Lodging | $2,056.35 |
| Food and Beverage | $504.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $9,842.04 | 2019 | |
| Intuitive Surgical, INC. | $8,114.48 | 2025 | |
| Medtronic, INC. | $163.75 | 2024 | Signia, Ligasure |
| Boston Scientific Corporation | $62.37 | 2020 | |
| Depuy Synthes Sales INC. | $25.13 | 2019 | |
| Ethicon US, LLC | $23.54 | 2022 | |
| Prytime Medical Devices, INC. | $15.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredric Pieracci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.